| Name | | |
| Last NAV | 108.63 | 89,206.00 |
| Date of Valuation | 2025/10/31 | 2025/10/31 |
| Sharpe Ratio | 0.76 | 0.00 |
| 3-Year Risk Return Ratio | 1.22 | 1.64 |
| Cumulative Performance (%) |
| +12.84% | +10.84% |
| +30.67% | +17.51% |
| +59.94% | +31.31% |
| +82.30% | +28.43% |
| +14.80% | +23.50% |
| +6.50% | +8.90% |
| +8.60% | +27.00% |
| N/A | N/A |
| Calendar Year Performance (%) |
| +14.80% | +23.50% |
| -29.90% | -24.90% |
| +6.50% | +8.90% |
| +39.40% | +34.60% |
| +8.60% | +27.00% |
| 3-Year Annualised Volatility | 19.63% | 15.08% |
| Funds House | J.P. Morgan Asset Management | J.P. Morgan Asset Management |
| Portfolio Manager | John Cho & Chun Yu Wong | Nicholas Weindling & Miyako Urabe & Shoichi Mizusawa |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 179000000 | USD 5567900 |
| Base Currency | USD | JPY |
| Sector | General | General |
| Geographic Allocation | Korea | Japan |
| Top Holdings |
| Samsung Electronics (9.80%) | Advantest (4.30%) |
| SK hynix (8.40%) | Keyence (4.90%) |
| LG Chem (3.60%) | Tokio Marine Holdings (5.10%) |
| Hyundai Motor (3.20%) | Shin-Etsu Chemical (4.00%) |
| SAMSUNG C&T (3.20%) | ITOCHU (5.00%) |
| NAVER (2.90%) | Seven & I Holdings (3.20%) |
| SAMSUNG BIOLOGICS (4.60%) | Asics (5.70%) |
| Samsung Electro-Mechanics (2.50%) | Hitach (7.00%) |
| Hana Financial Group (3.40%) | SECOM (3.20%) |
| Shinhan Financial Group (2.80%) | HOYA (4.00%) |
| Minimum Initial Investment | USD 1000 | JPY 100000 |
| Initial Sales Fee | 5.0% of NAV | 5.0% of NAV |
| Switching Fee | 1.0% of NAV | 1.0% of NAV |
| Maintenance Fee | Trustee fee:0.03%–0.125% of NAV p.a. (maximum 0.2%; subject to the NAV and a minimum of USD 12,500 p.a.) | Trustee fee:0.03%–0.125% of NAV p.a. (maximum 0.2%; subject to the NAV and a minimum of USD 12,500 per annum) |
| Redemption Fee | 0.5% of NAV | 0.5% of NAV |
| Launch Date | 1991/12/11 | 1969/07/31 |
| End of Financial Year | 30/09 | 30/09 |
| Country of Registry | Hong Kong | Hong Kong |
| Other Relevant Information | | |
| |